Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines

Front Immunol. 2023 Jun 12:14:1232965. doi: 10.3389/fimmu.2023.1232965. eCollection 2023.

¹ BioNTech, Mainz, Germany.
² South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
³ School of Public Health, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.
⁴ Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
⁵ Department of Microbiology and Immunology, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA, United States.
⁶ Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt, Germany.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1130539.].

Keywords: BA.1; Omicron; disease burden; sub-lineage; vaccine.